Pyxis Oncology GAAP EPS of -$0.30 beats by $0.05, revenue of $2.8M

Published 2 months ago Positive
Pyxis Oncology GAAP EPS of -$0.30 beats by $0.05, revenue of $2.8M
Auto
* Pyxis Oncology press release [https://seekingalpha.com/pr/20201906-pyxis-oncology-reports-second-quarter-2025-financial-results-and-provides-business-update] (NASDAQ:PYXS [https://seekingalpha.com/symbol/PYXS]): Q2 GAAP EPS of -$0.30 beats by $0.05.
* Revenue of $2.8M.
* Shares +3.54% AH.

MORE ON PYXIS ONCOLOGY

* Seeking Alpha’s Quant Rating on Pyxis Oncology [https://seekingalpha.com/symbol/PYXS/ratings/quant-ratings]
* Historical earnings data for Pyxis Oncology [https://seekingalpha.com/symbol/PYXS/earnings]
* Financial information for Pyxis Oncology [https://seekingalpha.com/symbol/PYXS/income-statement]